All Stories

  1. “They start on the zero-alcohol and they wanna try the real thing”: Parents' views on zero-alcohol beverages and their use by adolescents
  2. Which parents provide zero-alcohol beverages to adolescents? A survey of Australian parents' practices and intentions
  3. Experience of patients considering or using checkpoint inhibitors in cancer treatment: a systematic review of qualitative research
  4. 2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential
  5. Prevalence of parental supply of alcohol to minors: a systematic review
  6. Effects of food-based interventions in the management of chemoradiotherapy-induced nausea and vomiting: a systematic review
  7. ‘It is a life changing experience’: The experiences of living kidney donors who live in rural Australia
  8. Hypothesis‐free discovery of novel cancer predictors using machine learning
  9. A review of the utility of prognostic tools in predicting 6‐month mortality in cancer patients, conducted in the context of Voluntary Assisted Dying
  10. Review of psychological interventions in patients with cancer
  11. Examining social class as it relates to heuristics women use to determine the trustworthiness of information regarding the link between alcohol and breast cancer risk
  12. How does social class shape women's alcohol stockpiling during COVID-19?: A qualitative study in South Australia during the 2020 lockdown
  13. Adaptive capacity: A qualitative study of midlife Australian women's resilience during COVID-19
  14. Choosing and Managing Aged Care Services from Afar: What Matters to Australian Long-Distance Care Givers
  15. Demonstrating the importance of cultural considerations at end of life utilizing the perspective of Indian patients with cancer
  16. Psychosocial well-being and supportive care needs of cancer patients and survivors living in rural or regional areas: a systematic review from 2010 to 2021
  17. Communicating cancer and its treatment to Australian Aboriginal and Torres Strait Islander patients with cancer: a qualitative study
  18. Improving Survivors’ Quality of Life Post-Treatment: The Perspectives of Rural Australian Cancer Survivors and Their Carers
  19. Understanding the strategies rural cancer patients and survivors use to manage financial toxicity and the broader implications on their lives
  20. The psychosocial experiences and supportive care preferences of organ transplant recipients and their carers who live in regional Australia
  21. Now we are 30: 10 more years of MASCC
  22. Optimal Supportive Care for Patients With Metastatic Breast Cancer According to Their Disease Progression Phase
  23. Optimizing Rural People’s Access to Relevant Cancer Education and Support Using Peer-Led YouTube Films
  24. Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial
  25. Intrinsic Radiosensitivity Is Not the Determining Factor in Treatment Response Differences between HPV Negative and HPV Positive Head and Neck Cancers
  26. Second opinions in medical oncology
  27. Cancers of the corpus uteri treated in South Australian public hospitals: Trends in clinical management and survival across three decades
  28. Uncertainty upon uncertainty: supportive Care for Cancer and COVID-19
  29. Engagement of General Practice in an Australian Organised Bowel Cancer Screening Program: A Cross-Sectional Survey of Knowledge and Practice
  30. Monitoring TNM stage of female breast cancer and survival across the South Australian population, with national and international TNM benchmarking: A population-based cohort study
  31. Clinicians’ attitudes and perceived barriers and facilitators to cancer treatment clinical practice guideline adherence: a systematic review of qualitative and quantitative literature
  32. Dietary patterns of patients with psoriasis in a public institution in Brazil
  33. Supportive care in cancer—a MASCC perspective
  34. A review of factors influencing non-adherence to oral antineoplastic drugs
  35. Online interventions aimed at reducing psychological distress in cancer patients
  36. Online psychosocial interventions for posttreatment cancer survivors
  37. Influence of the human papillomavirus on the radio-responsiveness of cancer stem cells in head and neck cancers
  38. What are the attitudes of health professionals regarding patient reported outcome measures (PROMs) in oncology practice? A mixed-method synthesis of the qualitative evidence
  39. From participation to diagnostic assessment: a systematic scoping review of the role of the primary healthcare sector in the National Bowel Cancer Screening Program
  40. Development of a Smartphone Program to Support Adherence to Oral Chemotherapy in People with Cancer
  41. Ethical considerations relating to healthcare resource allocation decisions
  42. The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer
  43. Pain Education for Adolescents and Young Adults Living Beyond Cancer: An Interdisciplinary Meeting Report
  44. What is multidisciplinary cancer care like in practice? a protocol for a mixed-method study to characterise ambulatory oncology services in the Australian public sector
  45. “Some sort of fantasy land”: A qualitative investigation of appropriate prescribing in cancer care
  46. Time from diagnosis to treatment of colorectal cancer in a South Australian clinical registry cohort: how it varies and relates to survival
  47. Pre-diagnostic colonoscopies reduce cancer mortality - results from linked population-based data in South Australia
  48. Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response
  49. Alcohol and breast cancer risk: Middle-aged women’s logic and recommendations for reducing consumption in Australia
  50. What Caused My Cancer? Cancer Patients’ Perceptions on What May Have Contributed to the Development of Their Cancer: A Cross-Sectional, Cross-Country Comparison Study
  51. Medicinal cannabis for chemotherapy‐induced nausea and vomiting: prescribing with limited evidence
  52. Mobile-Based Oral Chemotherapy Adherence–Enhancing Interventions: Scoping Review
  53. Cytokinesis Block Micronucleus Cytome (CBMN Cyt) Assay Biomarkers and Their Association With Radiation Sensitivity Phenotype in Prostate Cancer Cases and DNA Repair Gene hOGG1 (C1245G) Polymorphism
  54. Using hospital registries in Australia to extend data availability on vulval cancer treatment and survival
  55. Mobile-Based Oral Chemotherapy Adherence–Enhancing Interventions: Scoping Review (Preprint)
  56. Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying
  57. Good training, systems and funding, not good luck: what hematologists and oncologists believe would make it easier for them to refer their cancer patients to psychosocial care
  58. Beyond PSA testing for prostate cancer
  59. The timeliness of patients reporting the side effects of chemotherapy
  60. Examining variation across treatment clinics in cancer patients’ psychological outcomes: results of a cross sectional survey
  61. Bowel cancer screening for women at midlife
  62. Web-Based Communication Strategies Designed to Improve Intention to Minimize Risk for Colorectal Cancer: Randomized Controlled Trial
  63. A systematic review of quantitative observational studies investigating psychological distress in testicular cancer survivors
  64. Access to clinical trials among oncology patients: results of a cross sectional survey
  65. Phase II study of celecoxib with docetaxel chemoradiotherapy followed by consolidation chemotherapy docetaxel plus cisplatin with maintenance celecoxib in inoperable stage III nonsmall cell lung cancer
  66. Survey of practices around pharmaceutical company funding for continuing professional development among medical oncologists and trainees in Australia
  67. Should disclosure of conflicts of interest in medicine be made public? Medical students’ views
  68. Web-Based Communication Strategies Designed to Improve Intention to Minimize Risk for Colorectal Cancer: Randomized Controlled Trial (Preprint)
  69. Web-Based Communication Strategies Designed to Improve Intention to Minimize Risk for Colorectal Cancer: Randomized Controlled Trial
  70. e-TC: Development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer
  71. Oesophageal cancer: Which treatment is the easiest to swallow? A review of combined modality treatments for resectable carcinomas
  72. Cocktail without hangover: in search for the optimal chemotherapy in the combined management of non-operable esophageal carcinomas
  73. Parallel multicentre randomised trial of a clinical trial question prompt list in patients considering participation in phase 3 cancer treatment trials
  74. Rolapitant in the Treatment of Nausea and Vomiting Associated With Chemotherapy
  75. History, development and future of cancer screening in Australia
  76. Cancer control-A global perspective
  77. Financial toxicity in clinical care today: a “menu without prices”
  78. How Australian general practitioners engage in discussions about alcohol with their patients: a cross-sectional study
  79. Prevention of breast cancer
  80. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
  81. 2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential
  82. 2016 updated MASCC/ESMO consensus recommendations: Anticipatory nausea and vomiting in children and adults receiving chemotherapy
  83. The consumer-driven development and acceptability testing of a website designed to connect rural cancer patients and their families, carers and health professionals with appropriate information and psychosocial support
  84. The importance of supportive care for patients with cancer
  85. Should clinical trials be approached differently for rare cancers?
  86. Improving uptake of wiki-based guidelines with Qstream education
  87. Spiritual history-taking
  88. Ethical issues with xenotransplantation clinical trials
  89. Palliative care specialists’ beliefs about spiritual care
  90. Message on a bottle: are alcohol warning labels about cancer appropriate?
  91. On the fragility of medical virtue in a neoliberal context: the case of commercial conflicts of interest in reproductive medicine
  92. Creating a safe space: A qualitative inquiry into the way doctors discuss spirituality
  93. Conceptual analysis of suffering in cancer: a systematic review